Emerging roles of circ_NRIP1 in tumor development and cancer therapy (Review)
- Authors:
- Xin Gao
- Yongbo Yu
- Haicun Wang
- Guanglin Liu
- Xinyu Sun
- Zhidong Wang
- Xingming Jiang
-
Affiliations: General Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China, General Surgery Department, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150086, P.R. China - Published online on: June 8, 2023 https://doi.org/10.3892/ol.2023.13907
- Article Number: 321
-
Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Lei M, Zheng G, Ning Q, Zheng J and Dong D: Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 19:302020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Li D, Luo H and Zhu X: Circular RNAs: The star molecules in cancer. Mol Aspects Med. 70:141–152. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Patop IL, Wüst S and Kadener S: Past, present, and future of circRNAs. EMBO J. 38:e1008362019. View Article : Google Scholar : PubMed/NCBI | |
|
Qu S, Zhong Y, Shang R, Zhang X, Song W, Kjems J and Li H: The emerging landscape of circular RNA in life processes. RNA Biol. 14:992–999. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chandler B, Hayashi M, Hayashi MN and Spiegelman S: Circularity of the replicating form of a single-stranded DNA virus. Science. 143:47–49. 1964. View Article : Google Scholar : PubMed/NCBI | |
|
Arnberg AC, Van Ommen GJ, Grivell LA, Van Bruggen EF and Borst P: Some yeast mitochondrial RNAs are circular. Cell. 19:313–319. 1980. View Article : Google Scholar : PubMed/NCBI | |
|
Kos A, Dijkema R, Arnberg AC, Meide PH and Schellekens H: The hepatitis delta (delta) virus possesses a circular RNA. Nature. 323:558–560. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Cocquerelle C, Mascrez B, Hétuin D and Bailleul B: Mis-splicing yields circular RNA molecules. FASEB J. 7:155–160. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Capel B, Swain A, Nicolis S, Hacker A, Walter M, Koopman P, Goodfellow P and Lovell-Badge R: Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell. 73:1019–1030. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Diener TO: Circular RNAs: Relics of precellular evolution? Proc Natl Acad Sci USA. 86:9370–9374. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Kozak M: Inability of circular mRNA to attach to eukaryotic ribosomes. Nature. 280:82–85. 1979. View Article : Google Scholar : PubMed/NCBI | |
|
Guan C, Liu L, Zhao Y, Zhang X, Liu G, Wang H, Gao X, Zhong X and Jiang X: YY1 and eIF4A3 are mediators of the cell proliferation, migration and invasion in cholangiocarcinoma promoted by circ-ZNF609 by targeting miR-432-5p to regulate LRRC1. Aging (Albany NY). 13:25195–25212. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Azhati B, Wang W, Rexiati M, Xing C and Wang Y: Circular RNA UBAP2 promotes the proliferation of prostate cancer cells via the miR-1244/MAP3K2 axis. Oncol Lett. 21:4862021. View Article : Google Scholar : PubMed/NCBI | |
|
Hu Z, Huang L, Wang W, Guan C, Zhao Y, Liu L and Jiang X: Long non-coding RNA FOXD2-AS1 promotes proliferation, migration, and invasion in cholangiocarcinoma through regulating miR-760/E2F3 axis. Dig Dis Sci. 67:546–558. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Peng F, Gong W, Li S, Yin B, Zhao C, Liu W, Chen X, Luo C, Huang Q, Chen T, et al: CircRNA_010383 acts as a sponge for miR-135a, and its downregulated expression contributes to renal fibrosis in diabetic nephropathy. Diabetes. 70:603–615. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Du WW, Zhang C, Yang W, Yong T, Awan FM and Yang BB: Identifying and characterizing circRNA-protein interaction. Theranostics. 7:4183–4191. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu L, Wang H, Yu S, Gao X, Liu G, Sun D and Jiang X: An update on the roles of circRNA-ZFR in human malignant tumors. Front Cell Dev Biol. 9:8061812022. View Article : Google Scholar : PubMed/NCBI | |
|
Garikipati VNS, Verma SK, Cheng Z, Liang D, Truongcao MM, Cimini M, Yue Y, Huang G, Wang C, Benedict C, et al: Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis. Nat Commun. 10:43172019. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Deng Z, Yang H, Pan X, Wei Z, Shen HB, Choi KS, Wang L, Wang S and Wu J: CircRNA-binding protein site prediction based on multi-view deep learning, subspace learning and multi-view classifier. Brief Bioinform. 23:bbab3942022. View Article : Google Scholar : PubMed/NCBI | |
|
Pamudurti NR, Bartok O, Jens M, Ashwal-Fluss R, Stottmeister C, Ruhe L, Hanan M, Wyler E, Perez-Hernandez D, Ramberger E, et al: Translation of circRNAs. Mol Cell. 66:9–21.e7. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Chen CK, Cheng R, Demeter J, Chen J, Weingarten-Gabbay S, Jiang L, Snyder MP, Weissman JS, Segal E, Jackson PK and Chang HY: Structured elements drive extensive circular RNA translation. Mol Cell. 81:4300–4318. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Wu X, Li Y, et al: Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer. 19:222020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang B, Yin H, Zhang H and Wang T: CircNRIP1 facilitates keloid progression via FXR1-mediated upregulation of miR-503-3p and miR-503-5p. Int J Mol Med. 47:702021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Li J, Bu H, Wang H, Zhang Y, Shen Q, Li M, Lu Z, Rong X, Zheng D and Peng Y: Circular RNA expression alteration identifies a novel circulating biomarker in serum exosomal for detection of alcohol dependence. Addict Biol. 26:e130312021. View Article : Google Scholar : PubMed/NCBI | |
|
Tao X, Shao Y, Yan J, Yang L, Ye Q, Wang Q, Lu R and Guo J: Biological roles and potential clinical values of circular RNAs in gastrointestinal malignancies. Cancer Biol Med. 18:437–457. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ghafouri-Fard S, Khoshbakht T, Hussen BM, Taheri M and Samsami M: Emerging role of circular RNAs in the pathogenesis of ovarian cancer. Cancer Cell Int. 22:1722022. View Article : Google Scholar : PubMed/NCBI | |
|
Pereira AL, Magalhães L, Pantoja RP, Araújo G, Ribeiro-Dos-Santos  and Vidal AF: The biological role of sponge circular RNAs in gastric cancer: Main players or coadjuvants? Cancers (Basel). 12:19822020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Li Z, Xu S and Guo J: Novel potential tumor biomarkers: Circular RNAs and exosomal circular RNAs in gastrointestinal malignancies. J Clin Lab Anal. 34:e233592020.PubMed/NCBI | |
|
Li T, Shao Y, Fu L, Xie Y, Zhu L, Sun W, Yu R, Xiao B and Guo J: Plasma circular RNA profiling of patients with gastric cancer and their droplet digital RT-PCR detection. J Mol Med. 96:85–96. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Reis-das-Mercês L, Vinasco-Sandoval T, Pompeu R, Ramos AC, Anaissi AKM, Demachki S, Assumpção PP, Vidal AF, Ribeiro-Dos-Santos  and Magalhães L: CircRNAs as potential blood biomarkers and key elements in regulatory networks in gastric cancer. Int J Mol Sci. 23:6502022. View Article : Google Scholar : PubMed/NCBI | |
|
Hurwitz LM, Pinsky PF and Trabert B: General population screening for ovarian cancer. Lancet. 397:2128–2130. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Killock D: Viral gene therapy active in ovarian cancer. Nat Rev Clin Oncol. 17:3912020. View Article : Google Scholar | |
|
Barber E and Matei D: Immunotherapy in ovarian cancer: We are not there yet. Lancet Oncol. 22:903–905. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Bairi EK, Singh S and Page LC: Revisiting platinum-resistant ovarian cancer: Advances in therapy, molecular biomarkers, and clinical outcomes. Semin Cancer Biol. 77:1–2. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lheureux S, Braunstein M and Oza AM: Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin. 69:280–304. 2019.PubMed/NCBI | |
|
Li H, Luo F, Jiang X, Zhang WJ, Xiang T, Pan QZ, Cai L, Zhao J, Weng D, Li Y, et al: CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype. J Immunother Cancer. 10:e0040292022. View Article : Google Scholar : PubMed/NCBI | |
|
Huang XY, Zhang PF, Wei CY, Peng R, Lu JC, Gao C, Cai JB, Yang X, Fan J, Ke AW, et al: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis. Mol Cancer. 19:922020. View Article : Google Scholar : PubMed/NCBI | |
|
Hong X, Liu N, Liang Y, He Q, Yang X, Lei Y, Zhang P, Zhao Y, He S, Wang Y, et al: Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer. 19:332020. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y and Gui R: Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells. J Gynecol Oncol. 31:e752020. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Cai J, Han X and Ren Y: Downregulation of circNRIP1 suppresses the paclitaxel resistance of ovarian cancer via regulating the miR-211-5p/HOXC8 axis. Cancer Manag Res. 12:9159–9171. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen LL: The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 21:475–490. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, et al: Upregulated HOXC8 expression is associated with poor prognosis and oxaliplatin resistance in hepatocellular carcinoma. Dig Dis Sci. 60:3351–3363. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang Y, Wang Z, Ying C, Hu J, Zeng T and Gao L: FMR1/circCHAF1A/miR-211-5p/HOXC8 feedback loop regulates proliferation and tumorigenesis via MDM2-dependent p53 signaling in GSCs. Oncogene. 40:4094–4110. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Castle PE, Einstein MH and Sahasrabuddhe VV: Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J Clin. 71:505–526. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ferrall L, Lin KY, Roden RBS, Hung CF and Wu TC: Cervical cancer immunotherapy: Facts and hopes. Clin Cancer Res. 27:4953–4973. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sundström K and Elfström KM: Advances in cervical cancer prevention: Efficacy, effectiveness, elimination? PLoS Med. 17:e10030352020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang H, Li X, Meng Q, Sun H, Wu S, Hu W, Liu G, Li X, Yang Y and Chen R: CircPTK2 (hsa_circ_0005273) as a novel therapeutic target for metastatic colorectal cancer. Mol Cancer. 19:132020. View Article : Google Scholar : PubMed/NCBI | |
|
Ma J, Du WW, Zeng K, Wu N, Fang L, Lyu J, Yee AJ and Yang BB: An antisense circular RNA circSCRIB enhances cancer progression by suppressing parental gene splicing and translation. Mol Ther. 29:2754–2768. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Ma N, Zhang Y, Wei H, Zhang H, Pang X, Li X, Wu D, Wang D and Zhang S: Circular RNA circNRIP1 promotes migration and invasion in cervical cancer by sponging miR-629-3p and regulating the PTP4A1/ERK1/2 pathway. Cell Death Dis. 11:3992020. View Article : Google Scholar : PubMed/NCBI | |
|
Hu JY, Yi W, Wei X, Zhang MY, Xu R, Zeng LS, Huang ZJ and Chen JS: MiR-601 is a prognostic marker and suppresses cell growth and invasion by targeting PTP4A1 in breast cancer. Biomed Pharmacother. 79:247–253. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang JX, Mai SJ, Huang XX, Wang FW, Liao YJ, Lin MC, Kung HF, Zeng YX and Xie D: MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling. Ann Oncol. 25:2196–2204. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Flores-Pérez A, Marchat LA, Rodríguez-Cuevas S, Bautista VP, Fuentes-Mera L, Romero-Zamora D, Maciel-Dominguez A, Cruz OH, Fonseca-Sánchez M, Ruíz-García E, et al: Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells. BMC Cancer. 16:3792016. View Article : Google Scholar : PubMed/NCBI | |
|
Bai Y, Luo Y, Liu S, Zhang L, Shen K, Dong Y, Walls CD, Quilliam LA, Wells CD, Cao Y and Zhang ZY: PRL-1 protein promotes ERK1/2 and RhoA protein activation through a non-canonical interaction with the Src homology 3 domain of p115 Rho GTPase-activating protein. J Biol Chem. 286:42316–42324. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lai Q, Wang M, Hu C, Tang Y, Li Y and Hao S: Circular RNA regulates the onset and progression of cancer through the mitogen-activated protein kinase signaling pathway. Oncol Lett. 22:8172021. View Article : Google Scholar : PubMed/NCBI | |
|
Siegel RL, Miller KD, Fuchs HE and Jemal A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Biller LH and Schrag D: Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA. 325:669–685. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xie M, Yu T, Jing X, Ma L, Fan Y, Yang F, Ma P, Jiang H, Wu X, Shu Y and Xu T: Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation. Mol Cancer. 19:1122020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang PF, Gao C, Huang XY, Lu JC, Guo XJ, Shi GM, Cai JB and Ke AW: Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma. Mol Cancer. 19:1102020. View Article : Google Scholar : PubMed/NCBI | |
|
Pan B, Qin J, Liu X, He B, Wang X, Pan Y, Sun H, Xu T, Xu M, Chen X, et al: Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer. Front Genet. 10:10962019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu F, Li R, Zhang R, He M and Zhang Y: Knockdown of circNRIP1 sensitizes colorectal cancer to 5-FU via sponging miR-532-3p. Oncol Rep. 46:2182021. View Article : Google Scholar : PubMed/NCBI | |
|
Huang E, Fu J, Yu Q, Xie P, Yang Z, Ji H, Wang L, Luo G, Zhang Y and Li K: CircRNA hsa_circ_0004771 promotes esophageal squamous cell cancer progression via miR-339-5p/CDC25A axis. Epigenomics. 12:587–603. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Zhu C and Lu X: Advances in serum biomarkers for early diagnosis of gastric cancer. Zhejiang Da Xue Xue Bao Yi Xue Ban. 48:326–333. 2019.(In Chinese). PubMed/NCBI | |
|
Zhou S, Guo Z, Zhou C, Zhang Y and Wang S: Circ_NRIP1 is oncogenic in malignant development of esophageal squamous cell carcinoma (ESCC) via miR-595/SEMA4D axis and PI3K/AKT pathway. Cancer Cell Int. 21:2502021. View Article : Google Scholar : PubMed/NCBI | |
|
McCabe EM and Rasmussen TP: LncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions. Semin Cancer Biol. 75:38–48. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Pastushenko I and Blanpain C: EMT transition states during tumor progression and metastasis. Trends Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, Van KA, Brown D, Moers V, Lemaire S, et al: Identification of the tumour transition states occurring during EMT. Nature. 556:463–468. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Wang S, Wang H, Cao J, Huang X, Chen Z, Xu P, Sun G, Xu J, Lv J and Xu Z: Circular RNA circNRIP1 acts as a microRNA-149-5p sponge to promote gastric cancer progression via the AKT1/mTOR pathway. Mol Cancer. 18:202019. View Article : Google Scholar : PubMed/NCBI | |
|
Shingu T, Ho AL, Yuan L, Zhou X, Dai C, Zheng S, Wang Q, Zhong Y, Chang Q, Horner JW, et al: Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation. Nat Genet. 49:75–86. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Payne KK: Cellular stress responses and metabolic reprogramming in cancer progression and dormancy. Semin Cancer Biol. 78:45–48. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Jiang Y, Xu L, Qu C, Zhang L, Xiao X, Chen W, Li K, Liang Q and Wu H: Circ-NRIP1 promotes glycolysis and tumor progression by regulating miR-186-5p/MYH9 axis in gastric cancer. Cancer Manag Res. 12:5945–5956. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu G, Li M, Wu J, Qin C, Tao Y and He H: Circular RNA circNRIP1 sponges microRNA-138-5p to maintain hypoxia-induced resistance to 5-Fluorouracil through HIF-1α-dependent glucose metabolism in gastric carcinoma. Cancer Manag Res. 12:2789–2802. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Fernandes E, Sores J, Cotton S, Peixoto A, Ferreira D, Freitas R, Reis CA, Santos LL and Ferreira JA: Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology. Theranostics. 10:4903–4928. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Shieh Y, Eklund M, Sawaya GF, Black WC, Kramer BS and Esserman LJ: Population-based screening for cancer: Hope and hype. Nat Rev Clin Oncol. 13:550–565. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ding X, Zheng J and Cao M: Circ_0004771 accelerates cell carcinogenic phenotypes via suppressing miR-1253-mediated DDAH1 inhibition in breast cancer. Cancer Manag Res. 13:1–11. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Soukup V, Babjuk M, Bellmunt J, Dalbagni G, Giannarini G, Hakenberg OW, Herr H, Lechevallier E and Ribal MJ: Follow-up after surgical treatment of bladder cancer: A critical analysis of the literature. Eur Urol. 62:290–302. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Reddy KRK, Dasari C, Duscharla D, Supriya B, Ram NS, Surekha MV, Kumar JM and Ummanni R: Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Angiogenesis. 21:79–94. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Xie R, Tang J, Zhu X and Jiang H: Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway. Biosci Rep. 39:BSR201819192019. View Article : Google Scholar : PubMed/NCBI | |
|
Si W, Huang W, Zheng Y, Yang Y, Liu X, Shan L, Zhou X, Wang Y, Su D, Gao J, et al: Dysfunction of the reciprocal feedback loop between GATA3- and ZEB2-nucleated repression programs contributes to breast cancer metastasis. Cancer Cell. 27:822–836. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Li H, Xu L, Li C, Zhao L, Ma Y, Zheng H, Li Z, Zhang Y, Wang R, Liu Y and Qu X: Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells. Mol Cancer. 13:1362014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX and Jia WH: Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 374:22–30. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Lei Y, Li YQ, Jiang W, Hong XH, Ge WX, Zhang Y, Hu WH, Wang YQ, Liang YL, Li JY, et al: A gene-expression predictor for efficacy of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst. 113:471–480. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Tang LQ, Li CF, Li J, Chen WH, Chen QY, Yuan LX, Lai XP, He Y, Xu YX, Hu DP, et al: Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst. 108:djv2912015. View Article : Google Scholar : PubMed/NCBI | |
|
Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D and Licitra L: Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer. 51:2130–2143. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lin J, Qin H, Han Y, Li X, Zhao Y and Zhai G: CircNRIP1 modulates the miR-515-5p/IL-25 axis to control 5-Fu and cisplatin resistance in nasopharyngeal carcinoma. Drug Des Devel Ther. 15:323–330. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li C, Zhu L, Fu L, Han M, Li Y, Meng Z and Qiu X: CircRNA NRIP1 promotes papillary thyroid carcinoma progression by sponging mir-195-5p and modulating the P38 MAPK and JAK/STAT pathways. Diagn Pathol. 16:932021. View Article : Google Scholar : PubMed/NCBI | |
|
Baldini C, Moriconi FR, Galimberti S, Libby P and Caterina DR: The JAK-STAT pathway: An emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. Eur Heart J. 42:4389–4400. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu ZK, Li C, Zhang RY, Wei D, Shang YK, Yong YL, Kong LM, Zheng NS, Liu K, Lu M, et al: EYA2 suppresses the progression of hepatocellular carcinoma via SOCS3-mediated blockade of JAK/STAT signaling. Mol Cancer. 20:792021. View Article : Google Scholar : PubMed/NCBI | |
|
Blaj C, Schmidt EM, Lamprecht S, Hermeking H, Jung A, Kirchner T and Horst D: Oncogenic effects of high MAPK activity in colorectal cancer mark progenitor cells and persist irrespective of RAS mutations. Cancer Res. 77:1763–1774. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Fu L, Huo J, Fitrat H, Kong Y, Zhang L, Shang C, Li G, Ji F, Fu X and Qiu X: CircNRIP1 exerts oncogenic functions in papillary thyroid carcinoma by sponging miR-653-5p and regulating PBX3 expression. J Oncol. 2022:20815012022. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF and Wong KK: Non-small-cell lung cancers: A heterogeneous set of diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Herbst RS, Morgensztern D and Boshoff C: The biology and management of non-small cell lung cancer. Nature. 553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cagney DN, Martin AM, Catalano PJ, Brown PD, Alexander BM, Lin NU and Aizer AA: Implications of screening for brain metastases in patients with breast cancer and non-small cell lung cancer. JAMA Oncol. 4:1001–1003. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
White RW and Horvitz E: Evaluation of the feasibility of screening patients for early signs of lung carcinoma in Web Search Logs. JAMA Oncol. 3:398–401. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Zhang K, Tan S, Xin J, Yuan Q, Xu H, Xu X, Liang Q, Christiani DC, Wang M, et al: Circular RNAs in body fluids as cancer biomarkers: The new frontier of liquid biopsies. Mol Cancer. 20:132021. View Article : Google Scholar : PubMed/NCBI | |
|
Lieben L: Diagnosis: RNA-seq for blood-based pan-cancer diagnostics. Nat Rev Cancer. 15:696–697. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Labelle M, Begum S and Hynes RO: Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 20:576–590. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
D'Ambrosi S, Visser A, Antunes-Ferreira M, Poutsma A, Giannoukakos S, Sol N, Sabrkhany S, Bahce I, Kuijpers MJE, Oude Egbrink MGA, et al: The analysis of platelet-derived circRNA repertoire as potential diagnostic biomarker for non-small cell lung cancer. Cancers. 13:46442021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen SW, Zhu SQ, Pei X, Qiu BQ, Xiong D, Long X, Lin K, Lu F, Xu JJ and Wu YB: Cancer cell-derived exosomal circUSP7 induces CD8+ T cell dysfunction and anti-PD1 resistance by regulating the miR-934/SHP2 axis in NSCLC. Mol Cancer. 20:1442021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang N, Nan A, Chen L, Li X, Jia Y, Qiu M, Dai X, Zhou H, Zhu J, Zhang H and Jiang Y: Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells. Mol Cancer. 19:1012020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Tong X, Zhou Z, Wang S, Lei Z, Zhang T, Liu Z, Zeng Y, Li C, Zhao J, et al: Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 17:1402018. View Article : Google Scholar : PubMed/NCBI | |
|
Preußer C, Hung LH, Schneider T, Schreiner S, Hardt M, Moebus A, Santoso S and Bindereif A: Selective release of circRNAs in platelet-derived extracellular vesicles. J Extracell Vesicles. 7:14244732018. View Article : Google Scholar : PubMed/NCBI | |
|
Yang T, Shen P, Chen Q, Wu P, Yuan H, Ge W, Meng L, Huang X, Fu Y, Zhang Y, et al: FUS-induced circRHOBTB3 facilitates cell proliferation via miR-600/NACC1 mediated autophagy response in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 40:2612021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen C, Yu H, Han FY, Lai X, Ye KH, Lei S, Mai M, Lai M and Zhang H: Tumor-suppressive circRHOBTB3 is excreted out of cells via exosome to sustain colorectal cancer cell fitness. Mol Cancer. 21:462022. View Article : Google Scholar : PubMed/NCBI | |
|
Liu H, Bi J, Dong W, Yang M, Shi J, Jiang N, Lin T and Huang J: Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis. Mol Cancer. 17:1612018. View Article : Google Scholar : PubMed/NCBI | |
|
Tang B, Zhang QF, Liu K and Huang Y: Exosomal circRNA FNDC3B promotes the progression of esophageal squamous cell carcinoma by sponging miR-490-5p and regulating thioredoxin reductase 1 expression. Bioengineered. 13:13829–13848. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Dai X, Guo X, Liu J, Cheng A, Peng X, Zha L and Wang Z: Circular RNA circGRAMD1B inhibits gastric cancer progression by sponging miR-130a-3p and regulating PTEN and p21 expression. Aging (Albany NY). 11:9689–9708. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Wang Y, Zhou G, Zhou JB, Tian Z and Xu J: circGRAMD1B contributes to migration, invasion and epithelial-mesenchymal transition of lung adenocarcinoma cells via modulating the expression of SOX4. Funct Integr Genomics. 23:752023. View Article : Google Scholar : PubMed/NCBI | |
|
Luo H, Peng J and Yuan Y: CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5. Cell Cycle. 22:1182–1195. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Liu J, Dai X, Guo X, Cheng A, Mac SM and Wang Z: Circ-OXCT1 suppresses gastric cancer EMT and metastasis by attenuating TGF-β pathway through the circ-OXCT1/miR-136/SMAD4 axis. Onco Targets Ther. 13:3987–3998. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Meng Y, Hao D, Huang Y, Jia S, Zhang J, He X, Liu D and Sun L: Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma. Mamm Genome. 32:448–456. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, et al: FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Res. 73:1981–1992. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Shi Z, Wang K, Xing Y and Yang X: CircNRIP1 encapsulated by bone marrow mesenchymal stem cell-derived extracellular vesicles aggravates osteosarcoma by modulating the miR-532-3p/AKT3/PI3K/AKT axis. Front Oncol. 11:6581392021. View Article : Google Scholar : PubMed/NCBI | |
|
Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, et al: METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol Cancer. 18:1102019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Hou C, Chen C, Guo Y, Yuan W, Yin D, Liu J and Sun Z: The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs. Mol Cancer. 19:1052020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen RX, Chen X, Xia LP, Zhang JX, Pan ZZ, Ma XD, Han K, Chen JW, Judde JG, Deas O, et al: N6-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis. Nat Commun. 10:46952019. View Article : Google Scholar : PubMed/NCBI |
